has received funding from the Medical Research Council [MR/W026961/1] and Arthritis UK (21530, 21812), which contributed to the original research articles summarised in this review
23 The main focus of this approach is to talk with patients who are initiating therapy about expected AEs, nonpharmacologic counseling, presence of any other GI conditions, and individualizing dose titrations
Overall, after 68 weeks, 83% of adults taking Wegovy lost 5% or more of their weight compared to 31% of adults taking a placebo
Um, all of this evidence is preliminary, so it always takes a while, like years, for this stuff, stuff, get it to get in there
Diarrhea and abdominal pain round out the GI effects
In patients with malignant tumors, ctDNA mainly consists of DNA from primary or metastatic tumor cells